Heated, humidified air for the common cold

Area of Science:

• Respiratory Medicine
• Evidence-Based Medicine
• Common Cold Treatment

Background:

• Heated, humidified air (steam) inhalation is a traditional remedy for the common cold.
• Theoretical benefits include improved mucus drainage and potential viral inactivation.
• This review updates previous findings on steam inhalation for cold symptom management.

Purpose of the Study:

• To evaluate the efficacy of heated water vapor (steam) inhalation for common cold treatment.
• To compare effects on cold symptoms, viral shedding, and nasal airway resistance.
• To synthesize evidence from randomized controlled trials.

Main Methods:

• Searched multiple databases (CENTRAL, MEDLINE, Embase, Current Contents) and clinical trial registries up to February/March 2017.
• Included randomized controlled trials (RCTs) investigating heated water vapor for common cold.
• Standard Cochrane review methodology was applied for study selection, data extraction, and analysis.

Main Results:

• Six trials (387 participants) were included; no new studies were added in the 2017 update.
• Evidence quality was low due to significant heterogeneity; results for symptomatic relief were inconsistent between fixed-effect and random-effects analyses.
• No significant differences were found in symptom resolution, viral shedding, or nasal resistance, with some minor adverse events reported.

Conclusions:

• Current evidence does not support the use of heated, humidified air for common cold treatment.
• No significant benefits or harms were demonstrated, even with specific devices like RhinoTherm.
• Further high-quality, double-blind, randomized trials with standardized protocols are needed.